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published The Bell Curve, a book that used a range of
statistical techniques to posit racial differences in intel-
ligence (Herrnstein & Murray, 1994). According to
Hammonds (2006), there have been two different types
of reactions to the publication. On one hand, the book
generated a host of detailed critiques that were devoted
to carefully dissecting the statistical analyses and de-
scribing every methodological flaw and inconsistency
in an effort to debunk the book’s findings (Devlin,
Fienberg, Resnick, & Roeder, 1997; Fischer et al.,
1996; Heckman, 1995). The second type of reaction
not only acknowledged the importance of the first, but
also pointed to its futility. This camp argued that meth-
odological critiques will fail to discredit theories on
racial difference in intelligence because they ignore
the fact that the research is being driven by more ideo-
logical forces (Aronowitz, 1996).
Extending Hammond’s typology, Kaufman’s (2008)
article falls squarely into the first camp in terms of the
way it responds to research that posits genetic* Tel.: þ1 614 247 4679; fax: þ1 614 292 6687.
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health. The first part of the critique is definitional and
argues that epidemiological analytic models that are
used to posit genetic explanations for racial health dis-
parities violate the statistical foundation of causal infer-
ence. The second part of the critique is more practical,
focusing narrowly on the methodology behind a 2001
New England Journal of Medicine (NEJM) paper that
compared the efficacy of ACE inhibitors with placebo
in Black and White patients (Exner, Dries, Domanski,
& Cohn, 2001).
Most of the points addressed in the critique have
been raised by Kaufman himself in earlier work. In a se-
ries of articles written over the last 10 years, Kaufman
and his co-author Richard S. Cooper have argued the
same points that are repeated here regarding the prob-
lems inherent in using counterfactual models to test
hypotheses of innate differences (Cooper & Kaufman,
1998; Kaufman & Cooper, 1999; Kaufman & Cooper,
2001; Kaufman, Cooper, & McGee, 1997). As echoed
in the present article, they have stated that while coun-
terfactual models are appropriate for testing theories of
discrimination (i.e. the causal factor is external to the
individual), they are not acceptable models when the
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to be intrinsic to the individual. The more basic claim
that an innate factor cannot be considered a causal
factor goes back even farther to the mid-1980s when
Paul W. Holland addressed the fundamental question
of what logically constitutes a cause in statistical mod-
eling (Holland, 1986). He concluded that, ‘‘for causal
inference, it is critical that each unit be potentially
exposable to any one of the causes. As an example,
the schooling a student receives can be a cause, in our
sense, of the student’s performance on a test, whereas
the student’s race or gender cannot’’ (Holland, 1986;
946). This argument has not been without its critics.
One such argument has questioned the appropriateness
of delimiting what can or cannot be a cause in statistical
inference. For example, Glymour (1986) argues that if
counterparts are conceivable, e.g. if there was a male
counterpart to my female self who was otherwise iden-
tical to me at the moment of conception, then counter-
factuals and causal relations are appropriate, even if the
exposed and unexposed counterparts cannot meaning-
fully be described as the same individual. Despite these
considerations, practical applications of counterfactual
models often allow for some violation of their logical
premises. As a result, many of the debates are relegated
to a philosophical domain that is often outside of the
purview of current practitioners of standard epidemio-
logical analyses (for more debate see Kaufman &
Cooper, 1999; Muntaner, 1999).
In the critique of the analysis of the Studies of Left
Ventricular Dysfunction (SOLVD) data, Kaufman again
raises a problem that he has frequently articulated in
earlier work regarding the problems of attempting to
statistically adjust for confounding variables, either
through the addition of controls or through matching
strategies, without accounting for the large number of
unmeasured factors that are related to the outcome
and differ between Blacks and Whites (Kaufman &
Cooper, 2001; Kaufman et al., 1997). The argument
follows that because racism creates imbalances on
such a large number of potential covariates, no statisti-
cal adjustment with covariates that we are able to mea-
sure will ever be sufficient to allow for counterfactual
contrasts. As a result, any remaining racial/ethnic
differences in a given outcome could always be due to
differences in unmeasured variables across the racial/
ethnic groups. This is why critics are so quick to fault
analyses (such as is exhibited with the SOLVD data)
that attribute unexplained variation in the outcome to
genetic differences between racial groups.
The repetitiveness of the critiques posited by Kauf-
man and the consistency with which they are ignoredin current research gets back to the second type of
reaction to The Bell Curve. This camp argues that meth-
odological critiques are futile because they are never
able to overcome the enticing logic that racial/ethnic
differences are caused by innate genetic factors and
not by societal inequities. Kaufman (2008) also notes
this at the end of his article when he cites a ‘‘strong pre-
dilection for racial essentialism in biological thinking’’.
These concerns raise the timely question as to whether
methodological critiques of research on racial differ-
ences in biology end up being more futile than func-
tional. If racial essentialist thinking is so ingrained in
the mindsets of researchers then specific methodologi-
cal critiques are unlikely to be an effective strategy in
countering the research. Instead of trying to convince
researchers of the methodological problems in their
analyses, we may be better served by going back to
the very foundations of racial essentialist thought in
science.
My own answer to this concern and one that I think
Kaufman would share is that these are not two com-
pletely separate endeavors. Methodological critiques
have the potential to push researchers to question
more fundamental assumptions of their understanding
of racial differences. There is, however, the continued
danger that current critiques are doomed to recycle
the same ideas over and over with little impact on cur-
rent research. Below, I enumerate several suggestions
that may help to avoid this fate.
First, the content of future methodological critiques
should be narrowly focused and include in-depth anal-
yses. Some of the strongest points made in Kaufman’s
article concern detailing specific errors committed in
the SOLVD analysis. One example is the observation
that baseline differences in risk bias the treatment effect
for the sicker population (i.e. the Black population in
the SOLVD data) towards the null when a ratio measure
of treatment effect is used. Kaufman also makes the key
point that there were no significant differences between
Blacks and Whites in the primary endpoint of mortality
and that this finding was essentially ignored in the
NEJM paper’s discussion in favor of a focus on the
more problematic outcome of hospitalization. An inter-
esting follow-up to the NEJM article is that a paper by
one of the original authors re-analyzed the SOLVD
data and published findings countering the NEJM
article’s conclusion of biological racial differences
(Dries, Strong, Cooper, & Drazner, 2002). This subse-
quent paper has been referenced to demonstrate the
tenuous nature of many findings of racial biological
difference in treatment effects and the role of methodo-
logical decisions in influencing conclusions of racial
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ful to the extent that they point out definable problems,
giving readers concrete evidence with which to evaluate
the conclusions. They also give researchers the tools
with which to avoid making the same types of mistakes
themselves, hopefully minimizing their occurrence and
subsequent need for further critiques.
The importance of specific and in-depth critiques
can be seen in a current trend in health disparities
research. As the increase in genetic data and related
technologies continues unabated, some disparities re-
searchers have begun to embrace the possibility of
genetic explanations for racial differences in their
research (Risch, 2006; Salari et al., 2005; Sinha, Larkin,
Elston, & Redline, 2006). One development concerns
the importation of the concept of geographical ancestry
into analyses of racial differences. Instead of discussing
genetic differences by race, some researchers have
instead chosen to refer to the possibility of differences
by ancestral background (Bamshad, 2005). For a good
deal of research, and particularly in medical practice,
this will likely only become a matter of semantics,
with race being switched out for the more palatable
term of ancestry (Frank & Frank, 2005). The underlying
logic of genetic racial differences remains untouched.
Other researchers are developing statistical measures
of ancestral background that are being marketed as
a way to account for and/or identify genetic differences
among contemporary population groups (Bamshad
et al., 2003; Shriver et al., 2005; Tang et al., 2005).
Yet these measures, and the ways in which they have
been used in studies of health disparities, have been
contested (Pfaff, Barnholtz-Sloan, Wagner, & Long,
2004; Romualdi et al., 2002; Weiss & Fullerton,
2005). As researchers who study racial differences
begin to incorporate ancestral arguments into their
research, it is important that they be informed of the
ways in which biogeographical ancestry is estimated
and the concerns with how different technologies are
currently being used in genetic association studies. To
make matters more complicated, many of the potential
pool of new users of this technology lack a familiarity
with genetic concepts that would allow them to be crit-
ical consumers of the knowledge. In such a situation,
methodological critiques that specify how these esti-
mates were created and how they do (or do not) differ
from older biological conceptualizations of race will
be invaluable. As ancestral estimates gain more promi-
nence in research on racial differences in complex dis-
ease, there is a corresponding need for specific
methodological critiques detailing the problems and
assumptions of this type of technology.A second recommendation for how methodological
critiques can be made to be more effective involves their
scope. While the content of methodological critiques
should be specific and narrow, their scope should be
broad. Racial essentialist thinking is pervasive in re-
search on racial/ethnic differences across a wide range
of health and behavioral outcomes. The present article
focused on the majority of epidemiological studies
that use observational data to test for racial differences
using the logic of counterfactual causal models. Exempt
from this critique would be all randomized controlled
trials that theoretically account for imbalances in both
observed and unobserved differences in covariate distri-
butions. Yet the long arm of a biological conceptualiza-
tion of race has touched even this gold standard of
epidemiological analyses. In 2005, the US Food and
Drug Administration (FDA) approved BiDil, the first
drug in the United States to be based on a patent formu-
lated in terms of its benefit to a specific racial or ethnic
group. BiDil, a combination of hydralazine and isosor-
bide dinitrate, was approved to treat heart failure in
African-Americans exclusively, potentially ushering in
a new era of race-based medicine and medical care.
The FDA’s approval of BiDil was based on the results
of a randomized control trial (A-Heft) that was so
successful it was halted early due to higher mortality
in the placebo group compared to the group receiving
BiDil (Taylor, Cohn, & Worcel, 2005).
The methodological flaws in the A-Heft trial, if there
are any, are likely minor. It was a well-run and costly
randomized controlled trial. Nonetheless, it merits one
of the most stringent of methodological critiques. The
logic behind the A-HeFT trial was that BiDil would
work differently in African-Americans because they
are biologically different than other racial groups, in
this case possibly due to lower levels of nitric oxide
in their blood (Taylor et al., 2005). But instead of mak-
ing lower levels of nitric oxide the determining factor
for admission into the trial, admission depended on
whether or not the participants self-identified as Black.
As detailed elsewhere by Kahn (2004), the decision to
include only Blacks in the A-Heft trial was motivated
largely by commercial interests. Because BiDil com-
bined two generic drugs, the only way to obtain
a new drug approval was through a race-specific patent.
The end result has been that BiDil biologized race by
suggesting that African-Americans benefit from
a drug in ways that Whites do not because of unspeci-
fied characteristics inherent to being Black. To date,
the response of Whites or other groups with heart fail-
ure receiving current standard therapy to BiDil remains
unknown.
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light the need for methodological critiques that are
broad in scope. If future critiques are limited to those
that demonstrate flawed statistical reasoning or poor
methodology we will end up missing a good deal of
influential research that biologizes racial differences
and is worthy of critique.
A third recommendation for future methodological
critiques is that researchers broaden their thinking about
what constitutes social influences versus biological or
genetic with regard to health. Causal processes that
are located outside the body (i.e. racism) have physio-
logical effects (i.e. inside the body). It is important to
remember that there are innumerable physiological
processes that are influenced by the environment and
whose effects are not pre-programmed in an individu-
al’s DNA (Krieger, 2005). Findings of racial differences
inside the body (e.g. racial differences in nitric oxide
levels) do not necessarily point to racial differences in
genotype. Rather, different social environments could
impinge on physiological processes to influence nitric
oxide levels. This is an important point because it
acknowledges the key role of gene/environment interac-
tions in influencing phenotype. The current push in re-
search on racial health disparities towards documenting
the role of racial differences in genotype is overstepping
the potentially much more important role of gene/envi-
ronment interaction in contributing to differential risk.
Researchers of racial differences in complex disease
should engage in more concerted interdisciplinary col-
laborations to explore the possibility of gene and envi-
ronment interactions and their role in contributing to
disparities. While an understanding of more complex
interactions is perhaps a long way off, the initiation of
collaborations now will help to pave the way for more
detailed work in the future (Cooper, 2003).
A fourth goal for future methodological critiques is
that they become self-generating. Researchers who
cite articles that have received critiques should also ref-
erence the critique in addition to the original findings.
In the case of the NEJM piece, Kaufman notes that it
has been cited repeatedly in support of the possibility
that genetic factors may be responsible for disparate
treatment effects across racial groups. All of these ref-
erences were published after two articles had ques-
tioned the results of the NEJM analysis, one using the
same data and finding no difference in treatment effects
and another using a meta-analysis to demonstrate no
significant racial differences in the effects of beta-
blockers or ACE inhibitors (Dries et al., 2002; Shekelle
et al., 2003). A more recent trial that purposively
included large enough numbers of Blacks and Whitesto conduct stable sub-group analyses found no signifi-
cant differences in the treatment effects of antihyper-
tensive treatment regimes in the development of
cardiovascular disease (Wright et al., 2005). The only
way for methodological critiques to gain any traction
is for researchers themselves to take on the responsibil-
ity of reporting these types of contradictory findings
when they exist.
A final point is that methodological critiques of
research on racial disparities in health should try to
avoid setting up ‘‘us’’ against ‘‘them’’ dichotomies. In
describing the limits of methodological critiques, Ham-
monds (2006) points out that many times such exercises
end up ‘‘pejoriatively’’ labeling scientists who are com-
mitted to uncovering the causes of racial disparities in
health as racists or antiquated relics from a previous
era. In an effort to avoid this fate, critics of more genet-
ically oriented health disparities research would do well
to remember that most of the researchers who study
health disparities are committed to identifying the
causes of disparities and eliminating them. This means
that one way to increase the effectiveness of such cri-
tiques is to appeal to specific scientific evidence or to
critique the lack thereof. If critiques are formulated in
such a way that they are detailed, accessible, and consis-
tent then I believe that there is hope that they will begin
to make a visible impact on the quality and quantity of
research that alleges genetic differences as a cause of
racial health disparities.
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